Short Interest in Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Declines By 20.0%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 255,300 shares, a drop of 20.0% from the September 15th total of 319,200 shares. Based on an average daily volume of 900 shares, the short-interest ratio is currently 283.7 days.

Kyowa Kirin Stock Performance

KYKOF remained flat at $20.97 on Tuesday. The firm has a 50 day moving average of $20.82 and a two-hundred day moving average of $18.60. Kyowa Kirin has a 52 week low of $15.78 and a 52 week high of $22.21.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.